Arrowhead Research Corp. (ARWR) Subsidiary Ablaris Raises $2.9M for Phase I Clinical Trial
Arrowhead Research Corp., a nanomedicine company focused on development programs in oncology, obesity and regenerative medicine, yesterday announced that majority-owned…